Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Intrauterine Fetal Death With Vanishing Gastroschisis and Post Mortem Examination Findings.

Jolley AF, Beare EJ, Granger J, Cord-Udy CL, Muller P, Moore L.

Pediatr Dev Pathol. 2017 Mar-Apr;20(2):158-162. doi: 10.1177/1093526616683872. Epub 2017 Jan 25.

PMID:
28326962
2.

Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long-term treatment with subcutaneous protein C concentrate.

Boey JP, Jolley A, Nicholls C, Lerda N, Duncan E, Gallus A, Ross DM, Sobieraj-Teague M.

Br J Haematol. 2016 Mar;172(5):811-3. doi: 10.1111/bjh.13538. Epub 2015 Jun 24. No abstract available.

PMID:
26103879
3.

Phenotypic variation of TTC19-deficient mitochondrial complex III deficiency: a case report and literature review.

Mordaunt DA, Jolley A, Balasubramaniam S, Thorburn DR, Mountford HS, Compton AG, Nicholl J, Manton N, Clark D, Bratkovic D, Friend K, Yu S.

Am J Med Genet A. 2015 Jun;167(6):1330-6. doi: 10.1002/ajmg.a.36968. Epub 2015 Apr 21. Review.

PMID:
25899669
4.

CASE REPORT OF INTRAUTERINE FETAL DEATH WITH VANISHING GASTROSCHISIS AND POST MORTEM EXAMINATION FINDINGS.

Jolley AF, Beare E, Granger J, Cord-Udy CL, Muller P, Moore L.

Pediatr Dev Pathol. 2014 Dec 9. [Epub ahead of print]

PMID:
25489782
5.

Monitoring and assessment of surface water acidification following rewetting of oxidised acid sulfate soils.

Mosley LM, Zammit B, Jolley AM, Barnett L, Fitzpatrick R.

Environ Monit Assess. 2014 Jan;186(1):1-18. doi: 10.1007/s10661-013-3350-9. Epub 2013 Jul 31.

PMID:
23900634
6.

De novo intragenic deletion of the autism susceptibility candidate 2 (AUTS2) gene in a patient with developmental delay: a case report and literature review.

Jolley A, Corbett M, McGregor L, Waters W, Brown S, Nicholl J, Yu S.

Am J Med Genet A. 2013 Jun;161A(6):1508-12. doi: 10.1002/ajmg.a.35922. Epub 2013 May 6. Review. No abstract available.

PMID:
23650183
7.

Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW; HALT PKD Study Group.

Kidney Int. 2012 Mar;81(6):577-85. doi: 10.1038/ki.2011.411. Epub 2011 Dec 28.

8.

Bacterial communities associated with flea vectors of plague.

Erickson DL, Anderson NE, Cromar LM, Jolley A.

J Med Entomol. 2009 Nov;46(6):1532-6.

PMID:
19960708
9.

A one year prospective study of the effect of life events and medication in the aetiology of schizophrenic relapse.

Hirsch S, Bowen J, Emami J, Cramer P, Jolley A, Haw C, Dickinson M.

Br J Psychiatry. 1996 Jan;168(1):49-56.

PMID:
8770428
10.

Magnetic resonance imaging in the diagnosis of suspected cornual pregnancy. A case report.

Lee C, Fogarty K, Jolley A.

J Reprod Med. 1995 Jun;40(6):474-6. No abstract available.

PMID:
7650664
11.

Therapeutic progress. IV: Treatment and prophylaxis of Pneumocystis carinii infection.

Jolley AE, Hastings JG.

J Clin Pharm Ther. 1995 Jun;20(3):121-30. Review.

PMID:
7593374
12.

Pharmacokinetics and distribution in tissue of FK-037, a new parenteral cephalosporin.

Wise R, Andrews JM, O'Neill P, Jolley A, Fowler C, Rogge MC.

Antimicrob Agents Chemother. 1994 Oct;38(10):2369-72.

13.

The in-vitro activity of a new highly active quinolone, DU-6859a.

Jolley A, Andrews JM, Brenwald N, Wise R.

J Antimicrob Chemother. 1993 Nov;32(5):757-63. No abstract available.

PMID:
8125840
14.

The value of surveillance cultures on neonatal intensive care units.

Jolley AE.

J Hosp Infect. 1993 Nov;25(3):153-9.

PMID:
7864912
15.

Continuous versus intermittent neuroleptic therapy in schizophrenia.

Jolley AG, Hirsch SR.

Drug Saf. 1993 May;8(5):331-9. Review. No abstract available.

PMID:
8099290
16.

Audit of the use of erythromycin in the treatment of community-acquired lower respiratory infections.

Jolley AE, Davies AJ, McLeod DT.

Respir Med. 1992 Nov;86(6):503-5.

PMID:
1470708
17.

Antibacterial therapy of community-acquired chest infections.

Davies AJ, Jolley A.

J Antimicrob Chemother. 1992 Jan;29(1):1-4. No abstract available.

PMID:
1737719
18.

Community-acquired pneumonia.

Davies AJ, Jolley A.

Lancet. 1991 May 4;337(8749):1101. No abstract available.

PMID:
1673525
19.
20.

Easing the inevitable.

Jolley A.

Nurs Times. 1990 Aug 22-28;86(34):36-8. No abstract available.

PMID:
2144342

Supplemental Content

Loading ...
Support Center